OAC

OMERS Administration Corp Portfolio holdings

AUM $15.6B
1-Year Est. Return 26.14%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$1.52B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,205
New
Increased
Reduced
Closed

Top Buys

1
+$993M
2
+$414M
3
+$242M
4
MRK icon
Merck
MRK
+$153M
5
GILD icon
Gilead Sciences
GILD
+$152M

Top Sells

1
+$424M
2
+$184M
3
+$153M
4
NKE icon
Nike
NKE
+$150M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$145M

Sector Composition

1 Technology 22.77%
2 Financials 16.4%
3 Industrials 10.28%
4 Healthcare 9.9%
5 Communication Services 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCTY icon
1176
Paylocity
PCTY
$6.08B
– –
-1,342
PLCE icon
1177
Children's Place
PLCE
$78.2M
– –
-42,500
QNCX icon
1178
Quince Therapeutics
QNCX
$19.8M
– –
-9,200
RAPT
1179
DELISTED
RAPT Therapeutics
RAPT
– –
-11,600
RDZN icon
1180
Roadzen
RDZN
$144M
– –
-46,323
SCLX icon
1181
Scilex Holding
SCLX
$49.2M
– –
-12,300
SFM icon
1182
Sprouts Farmers Market
SFM
$7.79B
– –
-6,903
SNCR
1183
DELISTED
Synchronoss Technologies
SNCR
– –
-115,000
TLSA icon
1184
Tiziana Life Sciences
TLSA
$158M
– –
-39,600
TRUE
1185
DELISTED
TrueCar
TRUE
– –
-1,476,082
U icon
1186
Unity
U
$12.7B
– –
-7,344
UPST icon
1187
Upstart Holdings
UPST
$2.85B
– –
-26,841
VIPS icon
1188
Vipshop
VIPS
$6.5B
– –
-75,776
VRCA icon
1189
Verrica Pharmaceuticals
VRCA
$104M
– –
-22,600
VTGN icon
1190
VistaGen Therapeutics
VTGN
$21.5M
– –
-103,400
VTYX
1191
DELISTED
Ventyx Biosciences
VTYX
– –
-26,200
UMAC icon
1192
Unusual Machines
UMAC
$1.28B
– –
-29,200
MAMO
1193
Massimo Group
MAMO
$40M
– –
-17,356
CTOR
1194
Citius Oncology
CTOR
$72.5M
– –
-104,500
BSLKW
1195
DELISTED
Bolt Projects Holdings Warrant
BSLKW
– –
-33,333
LGCY
1196
Legacy Education Inc
LGCY
$140M
– –
-14,800
ZENA
1197
ZenaTech Inc
ZENA
$116M
– –
-120,900
SOBO
1198
South Bow Corp
SOBO
$7.69B
– –
-330,000
ABPWW
1199
DELISTED
Abpro Holdings Warrant
ABPWW
– –
-25,000
KLRS
1200
Kalaris Therapeutics
KLRS
$106M
– –
-30,000
45 46 47
48
49